In mice, RETN is expressed predominantly in adipose tissue and its circulating concentration is markedly increased in genetic and dietinduced mouse models of obesity 7 but in human, RETN is expressed predominantly in monocytes and macrophages, being rarely expressed in adipose tissue. 8 RETN is also considered to be a biomarker of metabolic and inflammatory diseases, with increased resistin levels having been associated with metabolic disorders such as obesity, 9 ,10 insulin resistance, 11-13 type 2 diabetes 14 and atherosclerotic cardiovascular disease.
15,16
Resistin levels have been associated with variations in lipid levels in several adult populations. [17] [18] [19] A link between this cytokine and obesity has also been reported. 20, 21 But controversial studies have found no significant association of the circulating RETN level with obesity, insulin resistance and cardiovascular diseases.
22-24
The gene encoding RETN is located on chromosome 19p13 and a high heritability of serum resistin levels has been evaluated. 25 Several single-nucleotide polymorphisms (SNPs) described in the resistin gene have been associated with RETN levels.
26-28
Based on conflicting results of RETN polymorphisms association with obesity and RETN level in different populations, we aimed to study the relationship between five SNPs in RETN 420C/G; 44G/A; 62G/A;394C/G and 299 G/A with Resistin level and obesity in Tunisian volunteers.
| MATERIALS AND METHODS

| Study subjects
As descripted previously by Boumaiza et al.
29
, this study was composed by two groups (Obese/Nonobese). Obese group was composed of . In both groups we excluded subjects taking lipid-lowering drugs and all those having renal failure, thyroid disease and hepatic pathology.
A structured questionnaire was completed to the entire members of study. Sociodemographic characteristics, family and personal history, smoking habits, drug intake if any were collected.
The participants underwent physical examinations and laboratory tests. The examiners undertook training in the questionnaire collections and measures. The study was approved by the Hospital Medical Ethic
Committee and informed consent was obtained from all study subjects.
| Anthropometric parameters and blood pressure measurements
Weight and height were measured on the subjects barefooted and lightly clothed. Waist circumference (WC) was measured by trained examiner from the narrowest point between the lower borders of the rib cage and the iliac crest. BMI was calculated as body weight (kg)/height 2 (m 2 ) and obesity was defined as BMI≥30 kg/m 2 . 30 Blood pressure was measured three times from the left arm of seated subjects with a blood pressure monitor after 20 minutes of rest.
| Biochemical measurements
Blood was collected for laboratory testing after a 12 hours overnight fast. All biochemical parameters were performed on the Synckrom CX7 Clinical System using the Beckman reagents 
| Definitions of risk factors
Dyslipidemia was defined as LDL-C concentration ≥4.1 mmol/L and/or HDL-C concentration ≤1 mmol/L and/or TG concentration 1.71 mmol/L. 33, 34 Hypertension was defined as more than 140/90 mmHg or actually receiving antihypertensive medication.
35
Diabetes mellitus was defined as fasting glucose superior a 7 mmol/L or currently receiving anti diabetic treatment.
| DNA analysis
Genomic DNA was isolated from peripheral blood leucocytes by the salting out method. 36 Genotyping of polymorphisms were determined by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and the digest product were resolved by 2% agarose gel electrophoresis and visualized by ethidium bromide staining. 
| Statistical analysis
| RESULTS
| Patient characteristics
The clinical and biological characteristics of our study were presented in Table 1 (modified from table 1 by Boumaiza et al. 29 ).
The prevalence of hypertension, diabetes, Metabolic Syndrome and cardiovascular disease was higher in obese group (P<.001).
Compared with nonobese subjects, the obese subjects had higher weight, waist circumference, TG, TC, HOMA-IR, insulin and Resistin levels but lower HDL-C concentration. Dyslipidemia frequencies (P=.923), Daily energy intake (P=.636) and LDL-C concentrations (P=.262) did not showed significant differences between the two groups.
| Association between Resistin polymorphisms and Resistin level
Results given in Table 2 revaluated that the serum Resistin levels present no significant association with all RETN polymorphisms.
| Association between Resistin polymorphisms and obesity in all studied population
After adjustment for confounding parameters (age, gender, smoking status, HTA, diabetes, dyslipidemia, and cardiovascular disease), the OR of obesity associated with mutated genotypes at 420C/G compared with normal genotype was as: OR=2.17; 95% CI [1.28-3.68],
P=.004.
There was no significant association between 44G/A, 394 C/G, 62
G/A and 299 G/A.
| Correlation between serum Resistin levels and biological and anthropometric parameters
Results given in Table 3 revealed that the serum Resistin concentration was significantly associated with BMI (P=.047).
Whereas no statistical differences were observed for HOMA-IR, WC, TG and HDL-C. 
| Haplotype frequency distribution and Resistin level association
SNP analyzer showed 22 haplotypes (H), two of them seem to be significantly associated with obesity (Table 4) .
Haplotypes follow this order; 420C/G, 44G/A, 62G/A, 394 C/G and 299G/A ( 
| DISCUSSION
Obesity is multifactor disease which many factors interact together like genetic, metabolic and environmental factors. There is some urgency in identifying specific genetic influences on overweight and obesity and their interactions with concrete environmental exposures.
Indeed, in the Tunisian population, obesity became rather frequent pathology.
In adult Tunisian women aged 20-59, prevalence of obesity and abdominal obesity were, respectively, 22.6% and 29.2%. 38 Several association studies revealed the contribution of RETN gene variants to the pathogenesis of obesity; however, they were inconclusive or inconsistent. These discrepancies may be attributed to differences in sample size, ethnicity, disease status and probably these studies did not analyze the whole gene.
39
In our study we found a significant difference between obese/ non-obese subjects and Resistin levels, it is clear that obesity is characterized by high levels of Resistin with cut-off value of 11.55 ng/ mL to separate normal weight from overweight was observed (Sensitivity=61.5%; Specificity=52.6%).
In agreement with our study, Amal et al. 39 in Egyptian population reported that RETN levels were measured respectively as T A B L E 3 Association between resistin polymorphisms and obesity in all studied population controls (1.33±0.27 ng/mL) and obese patients (2.43±1.5 ng/mL).
In India, Kumar et al. 13 found a significant difference in serum
Resistin levels between 305 women with metabolic syndrome (14.63±11.02 ng/mL) and 310 women without metabolic syndrome (9.61±6.28 ng/mL).
In Iranian study, Takhshid et al. 40 23 he did not observe significant differences in serum Resistin levels between the metabolic syndrome and non metabolic syndrome groups.
Menzaghi et al. 25 estimated that up to 70% of the variation in circulating resistin levels can be explained by genetic factors but this divergence in results may be explained also by ethnic origin, life style, food composition and the variations in adipose tissue of the body distribution.
In our study we found significant negative correlation between
Resistin serum levels and BMI R=−0.155 (P=.045). In agreement with our study results, Yannakoulia et al. 41 studied the dynamic between the RETN level and body fat mass in healthy subjects, reported that serum RETN levels were negatively correlated with BMI and body fat in young participants. Several studies confirmed this result.
42-44
Booth et al. 45 reported that the relation between subcutaneous adipose tissue and RETN was stronger than the relation of other measures of obesity to RETN and this is may be explained by expression mode of RETN.
In fact, RETN is not expressed by adipocytes but is secreted by macrophages located within adipose tissue depots. 8 So, circulating RETN is not directly related to adiposity levels but to the degree of inflammation within the adipose tissue depots.
45
In our population we aimed to study not only the relationship between Resistin level and obesity but also to exanimate this relation with some polymorphisms in RETN gene.
Our study revaluated that the serum RETN levels present no significant association with all RETN polymorphisms except for 420
For 420C/G SNP we noted an increase in serum resistin in GG carriers vs CC and CG. This is association between G allele and serum resistin was controversies in same studies 25, 46 but reported in the Koreans population 47 and Malaysians study.
26
In other hand, RETN 420C/G has been studied extensively in regards to obesity risk but with conflicting reports and that the GG F I G U R E 1 Sensibility and specificity of resistin level in study population. genotype have been reported similarity to our results to have a higher prevalence of obesity 48, 49 and the G allele has been associated with increased BMI, weight, body fat mass, and WC. 9, 50 The effect of the 420 C/G SNP can be explained by his localization wish appears to have a key functional consequence and to increase the resistin promoter activity observed with G allele. 14, 47 In fact, the 
51,52
For the 44G/A polymorphism our results were not significant but, Boumaiza et al. 53 found a association between 44AA and Metabolic syndrome risk after adjustment to confounding parameters and in a
Turkish population, the 44G/A polymorphism is associated with obesity and insulin-related phenotypes. 54 But, Sentinelli et al. 55 could not found any significant differences.
Several SNPs in the 3′ UTR of RETN (like 44 G/A and 62 G/A)
had been associated with resistin levels in Caucasians and Japanese population.
19,46
The from the AATAAA polyadenylation signal and may be therefore affect polyadenylation of RETN mRNA.
19
A regards to 394 C/G (promoter 5′ flanking region) and 62 G/A, there is no association between these SNPs and obesity and the lack of association was also reported in many study 19, 46, 53, 55, 59 and this may be explained by differential distributions of risk factors, genetic predisposition and environmental conditions. However, 62 G/A it has been reported to be associated with hypertension 60,61 and type 2 diabetes 61 and this may explain by he's localization in a critical region (3′UTR). Nambiar et al. 62 reported a positive correlation between BMI and resistin levels but no significant correlation was found between the genotypes analyzed of 62 G/A polymorphism and RETN levels. Similar findings were reported in the study from Spain.
63
As regards to 299 G/A SNP located at intron 2 of resistin gene, we have report any significant association of serum resistin with obesity and our results was also reported by Miyamoto et al. 49 and Suriyaprom et al. 64 Also, Wang et al. 65 added that RETN gene variants may influence insulin sensitivity interaction in obese subjects. On the contrary, Osawa et al. 66 he did not found this association with RETN +299 G/A with obesity. Also, this dissimilarity might be results too many interaction factors like a limited number of subjects, the ethnic specificity of population or also the variation in the entry criteria of subjects.
In our study population, comparison of the haplotype frequencies between obese and non-obese groups; showed significant difference for two haplotypes H4 "CGGCA" which seems to be protective and it occurred more frequently in the non-obese than in obese group (P=.030) but H5 "GGGGA" seems to be the most Haplotype associated to obesity risk with OR=3. In conclusion, this study showed that only RETN 420 C/G Polymorphism were associated with obesity and Leptin concentration in our population.
Also, when combined in haplotypes a synergic effect was observed in Resistin levels and obesity risk.
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